Far Fewer Mental Health Medications are Recommended for Listing on Government Drug Plans When Compared to Non-mental Health Medications?

This very enlightening study questions how genuine our government’s call is for improved mental health treatment. While medication is only one treatment option, for many impacted by a mental health disorder, the right medication treatment can be life changing. This study published by the Canadian Health Policy Institute (CHPI), compares decisions on access to medications…

Are we Prescribing too Many Antipsychotic Medications for Children with ADHD?

A recent study by the Institute for Clinical Evaluative Sciences found almost 12 per cent of children and youth with attention deficit hyperactivity disorder, or ADHD, were prescribed antipsychotics like Risperdal, Zyprexa and Seroquel. Since the study found that 5% of Ontario children have ADHD, this means that .06% of children may be receiving antipsychotic…

Follow–up from Health Canada regarding Generic Forms of Concerta

This past week, a follow-up letter was received from Marion Law, the Director General of Health Canada’s Therapeutic Products Directorate (TPD) addressing discussions during the Oct 31 meeting with Janssen, CADDAC  and ADHD medical experts. The letter noted that: During the meeting with Health Canada, concerns were expressed by patient and physician organizations about the…

Recent Meeting with Health Canada Regarding Generic Concerta

On October the 31st CADDAC and CADDRA, as well as other stake holders, met with Health Canada to present our activities over the past six years and express our continued concerns in regards to the bioequivalency, or more accurately the lack of therapeutic equivalence, of the generic forms of the brand name ADHD medication Concerta. …